Top Medical Stocks To Invest In Right Now

Cyndee Weston can barely remember the last time she didn’t have to switch health plans during an Affordable Care Act sign-up season. By her count, she has been on five plans in five years.

Every fall, after she has spent months figuring out her insurance plan’s deductibles, doctor networks, list of covered drugs and other fine print, she receives notice that the policy will be canceled as of Dec. 31.

Because her job doesn’t come with insurance, “it’s agonizing going through all the plans and trying to compare,” said Weston, 55, who has diabetes and a history of melanoma. “Every year it’s the same scenario: ‘We’re not going to renew your policy.'”

Under the market-based system set up by the ACA, individuals are encouraged to “shop around” each year to find insurance that better suits their medical needs and income. In fact like Weston, a trade association executive in Sulphur, Okla. they are often forced to do so when plans drop out of the local market or eliminate preferred hospitals and doctors from the network.

Top Medical Stocks To Invest In Right Now: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Spark Therapeutics (NASDAQ:ONCE) was the target of some unusual options trading activity on Thursday. Investors acquired 551 put options on the company. This represents an increase of 884% compared to the average volume of 56 put options.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Spark Therapeutics (ONCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    So, which biotech stocks should you consider buying in June? That’s a question we posed to three of our healthcare-focused investors. Interestingly enough, mid-cap biotech stocks are the clear flavor of the month. If biotech is on your radar in June, our investors suggest you consider Ionis Pharmaceuticals (NASDAQ:IONS), Spark Therapeutics (NASDAQ:ONCE), and Alnylam Pharmaceuticals (NASDAQ:ALNY).

  • [By Cory Renauer]

    Here’s what you need to know about the catalysts that could send these stocks soaring, or plummeting, in the third quarter.

    Company Market Cap Incoming Catalyst
    Spark Therapeutics Inc. (NASDAQ:ONCE) $3.09 billion Clinical trial results
    Zogenix, Inc. (NASDAQ:ZGNX) $1.56 billion Clinical trial results
    Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) $593 million PDUFA date

    Data source: Yahoo! Finance.

  • [By Shane Hupp]

    Spark Therapeutics (NASDAQ:ONCE)‘s stock had its “market perform” rating reiterated by Leerink Swann in a research report issued on Monday, The Fly reports. They currently have a $74.00 price objective on the biotechnology company’s stock, up from their previous price objective of $55.00. Leerink Swann’s price objective would indicate a potential upside of 4.71% from the stock’s current price.

  • [By Ethan Ryder]

    FIL Ltd cut its stake in Spark Therapeutics Inc (NASDAQ:ONCE) by 9.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,134 shares of the biotechnology company’s stock after selling 8,084 shares during the period. FIL Ltd owned approximately 0.21% of Spark Therapeutics worth $5,270,000 at the end of the most recent reporting period.

Top Medical Stocks To Invest In Right Now: Northwest Biotherapeutics, Inc.(NWBO)

Advisors’ Opinion:

  • [By ]

    Northwest Biotherapeutics (OTC:NWBO) presented underwhelming preliminary data from a late-stage study of DCVax-L in brain cancer.

    Community Health Systems (NYSE:CYH) amended to extend the Early Tender Deadline and the Expiration Date for each Exchange Offer announced earlier.

  • [By ]

    The last time we left Northwest Biotherapeutics (OTC:NWBO), I stated in a fairly cautious article that there are persistent risks associated with an investment in this company. Back in November, I did not feel that the benefits outweighed the risks for this small cap equity.

Top Medical Stocks To Invest In Right Now: Dawson Geophysical Company(DWSN)

Advisors’ Opinion:

  • [By Max Byerly]

    Dawson Geophysical (NASDAQ:DWSN) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Monday.

  • [By Logan Wallace]

    Dawson Geophysical (NASDAQ:DWSN) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c-” rating in a research note issued on Monday.

Top Medical Stocks To Invest In Right Now: TripAdvisor, Inc.(TRIP)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Booking Holdings Inc. (NASDAQ: BKNG) to post quarterly earnings at $10.67 per share on revenue of $2.87 billion after the closing bell. Booking Holdings shares gained 0.99 percent to $2,183.00 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) reported stronger-than-expected results for its first quarter on Tuesday. Tripadvisor shares climbed 20.55 percent to $46.75 in the after-hours trading session.
    Analysts are expecting Anheuser-Busch InBev SA/NV (NYSE: BUD) to have earned $0.89 per share on revenue of $13.06 billion in the latest quarter. Anheuser-Busch will release earnings before the markets open. Anheuser-Busch shares gained 0.77 percent to $99.00 in after-hours trading.
    Extreme Networks, Inc (NASDAQ: EXTR) reported downbeat earnings for its third quarter and issued weak Q4 guidance. Extreme Networks shares fell 28.51 percent to $8.40 in the after-hours trading session.
    Before the opening bell, Ameren Corporation (NYSE: AEE) is projected to report quarterly earnings at $0.57 per share on revenue of $1.55 billion. Ameren shares dropped 2.78 percent to close at $56.91 on Tuesday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Dan Caplinger]

    The stock market jumped on Wednesday, with the Dow Jones Industrial Average finishing up by triple digits and other major benchmarks following suit with similar-sized gains. Attention once again focused on the oil market, where prices rebounded to climb to new multiyear highs above $71 per barrel. Investors seem to see oil’s strength as indicating stronger levels of economic activity, choosing not to fear any adverse pressure on prices that could result from higher costs for consumers and businesses that rely on energy products. Good news from several individual companies also helped keep sentiment positive. Axon Enterprise (NASDAQ:AAXN), TripAdvisor (NASDAQ:TRIP), and iQiyi (NASDAQ:IQ) were among the best performers on the day. Here’s why they did so well.

  • [By Demitrios Kalogeropoulos]

    TripAdvisor’s(NASDAQ:TRIP) business is barely growing, but Wall Street couldn’t be happier. The online travel booking specialist’s stock jumped over 20% immediately following its first-quarter earnings report that showed a 2% sales uptick while earnings fell 62% to $5 million.

  • [By Adam Levy]

    If you looked at the recent stock performances of TripAdvisor (NASDAQ:TRIP) and Booking Holdings (NASDAQ:BKNG), TripAdvisor has been, by far, the better investment. But zooming out to look at their respective price changes over the last several years tells a much different story.

  • [By Lisa Levin] Gainers
    Amedica Corporation (NASDAQ: AMDA) rose 31.3 percent to $4.11 in pre-market trading after climbing 181.98 percent on Tuesday.
    ZAGG Inc (NASDAQ: ZAGG) rose 18.7 percent to $13.65 in pre-market trading after the company posted better-than-expected Q1 earnings.
    TripAdvisor, Inc. (NASDAQ: TRIP) rose 18.6 percent to $46.00 in pre-market trading after the company reported stronger-than-expected results for its first quarter on Tuesday.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 15 percent to $2.08 in pre-market trading after reporting Q4 results.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 9.8 percent to $49.00 in pre-market trading following a big Q1 beat. The company raised its fiscal 2018 sales growth guidance from 16-18 percent to 18-20 percent.
    Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 8.1 percent to $21.06 in pre-market trading following Q1 results.
    OPKO Health, Inc. (NASDAQ: OPK) shares rose 6.8 percent to $3.44 in pre-market trading following Q1 beat.
    Tel-Instrument Electronics Corp. (NYSE: TIK) rose 6.7 percent to $3.20 in pre-market trading after surging 25.37 percent on Tuesday.
    KBS Fashion Group Limited (NASDAQ: KBSF) rose 6.4 percent to $5.84 in pre-market trading after jumping 9.36 percent on Tuesday.
    Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) rose 6.6 percent to $8.26 in pre-market trading after reporting Q2 earnings.
    New Relic, Inc. (NYSE: NEWR) rose 6.3 percent to $82.00 in pre-market trading following Q4 results.
    Match Group, Inc. (NASDAQ: MTCH) rose 5.8 percent to $38.43 in pre-market trading after reporting upbeat Q1 earnings.
    Prestige Brands Holdings, Inc. (NYSE: PBH) rose 5.2 percent to $30.62 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top Medical Stocks To Invest In Right Now: J & J Snack Foods Corp.(JJSF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ValuEngine upgraded shares of J & J Snack Foods (NASDAQ:JJSF) from a hold rating to a buy rating in a research note issued to investors on Tuesday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on J & J Snack Foods (JJSF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *